Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 12
Original Research
Budget Impact Analysis of Switching to Rituximab’s Biosimilar in Rheumatology and Cancer in 13 Countries Within the Middle East and North Africa
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,097 | Dovepress* | 4,195+ | 836 | 5,031 | |
| PubMed Central* | 902 | 204 | 1,106 | ||
| Totals | 5,097 | 1,040 | 6,137 | ||
| *Since 15 September 2020 | |||||
View citations on PubMed Central and Google Scholar